Suan Tuang

Suan Tuang is an Associate at TCGX, a life sciences investment firm, where he focuses on identifying and evaluating investment opportunities in private and public biotechnology companies. His current responsibilities include scientific due diligence, market assessment, and assisting with transaction execution for biotech assets and therapeutics within TCGX's portfolio.

Previously, Suan worked as an Investment Analyst at Foresite Capital Management, concentrating on funding private and public biotech firms, and as an Associate Research Analyst at Eventide Asset Management, gaining experience in both public equities and healthcare sector research. His investment coverage spans biotechnology, therapeutics, and life sciences industries, with a particular emphasis on companies developing novel drug modalities and platform technologies.

Dr. Tuang holds an M.D. in Health Sciences and Technology from Harvard Medical School, a Ph.D. in Chemical Biology from MIT, and a B.S. in Chemistry from MIT. He is recognized for his interdisciplinary expertise bridging medicine, chemical biology, and scientific analysis, and is a former Amgen Scholar and Soros Fellow, underscoring his contributions to academic research and scientific innovation within the investment sector.